Clinical Validation of a Blood Loss Monitoring System
Prospective Multicenter Clinical Validation of a Novel Multifunctional Intraoperative Blood Loss Monitoring System
1 other identifier
observational
120
1 country
3
Brief Summary
This observational study aims to evaluate the practicality of a novel multifunctional intraoperative blood loss monitoring system in real-world surgical settings. The primary questions it seeks to address are: Using the direct measurement method as the reference standard, what is the magnitude of measurement error of the monitoring system, and does it tend to overestimate or underestimate blood loss? Does the monitoring system demonstrate superior accuracy compared with visual estimation, the gravimetric method, and the hemoglobin concentration-based method? During surgery, intraoperative blood loss will be measured simultaneously using five approaches: the novel multifunctional monitoring system, the direct measurement method, visual estimation, the gravimetric method, and the hemoglobin concentration method. These measurements will be conducted without interfering with the surgical procedure.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Sep 2025
Shorter than P25 for all trials
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 10, 2025
CompletedFirst Submitted
Initial submission to the registry
May 5, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 30, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
May 30, 2026
CompletedFirst Posted
Study publicly available on registry
June 1, 2026
CompletedJune 3, 2026
April 1, 2026
9 months
May 5, 2026
May 31, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Absolute error of the automatic intraoperative blood loss monitor compared with the direct measurement method
Absolute error is defined as the numerical difference between intraoperative blood loss measured by the automatic intraoperative blood loss monitor and intraoperative blood loss measured by the direct measurement method. A positive value indicates that the monitor overestimates blood loss compared with the direct measurement method, whereas a negative value indicates underestimation. Unit of Measure: Milliliters (mL)
At the end of surgery
Secondary Outcomes (7)
Percentage error of the automatic intraoperative blood loss monitor compared with the direct measurement method
At the end of surgery
Absolute error of visual estimation compared with the direct measurement method
At the end of surgery
Absolute error of the gravimetric method compared with the direct measurement method
At the end of surgery
Absolute error of the hemoglobin concentration-based method compared with the direct measurement method
24 hours after surgery
Intraclass correlation coefficient between the automatic intraoperative blood loss monitor and the direct measurement method
At the end of surgery
- +2 more secondary outcomes
Study Arms (1)
Self-controlled
This study includes a single self-controlled cohort of patients undergoing urological and general surgical procedures. All participants will undergo simultaneous intraoperative blood loss assessment using five different methods within the same surgical procedure: a novel multifunctional intraoperative blood loss monitoring system, the direct measurement method (reference standard), visual estimation, the gravimetric method, and the hemoglobin concentration-based method. No intervention is applied in this observational study. All measurements are performed according to a predefined protocol and do not interfere with the standard surgical workflow. The purpose of this design is to enable within-subject comparison of measurement accuracy across different methods under identical clinical conditions.
Eligibility Criteria
The study population will be recruited from adult patients undergoing elective urological and general surgical procedures at two tertiary hospitals in China, including Lanzhou University Second Hospital and Lanzhou University First Hospital. Participants will be selected from routine clinical practice settings where intraoperative blood loss monitoring is required. This population represents adult surgical patients managed under standard perioperative care, providing a real-world clinical context for evaluating intraoperative blood loss measurement methods.
You may qualify if:
- Patients undergoing elective urological or general surgical procedures
- Age 18 years or older
- Preoperative hemoglobin concentration available
- Intraoperative blood loss assessment required during surgery
You may not qualify if:
- Patients with incomplete intraoperative blood loss measurement data,
- Severe hemolysis or other conditions that may affect hemoglobin measurement
- Emergency surgery
- Intraoperative blood loss assessment required during surgery 24 hours after surgery
- Refusal to participate, when applicable
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Gansu Provincial People's Hospital
Lanzhou, Gansu, 730030, China
Lanzhou University Frist Hospital
Lanzhou, Gansu, 730030, China
Lanzhou University Second Hospital
Lanzhou, Gansu, 730030, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Day
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor; Chief Physician
Study Record Dates
First Submitted
May 5, 2026
First Posted
June 1, 2026
Study Start
September 10, 2025
Primary Completion
May 30, 2026
Study Completion
May 30, 2026
Last Updated
June 3, 2026
Record last verified: 2026-04